Introduction 68
Changes in human behaviour, such as excessive food intake and/or insufficient physical activity, 69 have made obesity a worldwide epidemic (1) . Furthermore, obesity is a significant risk factor for the 70 development of insulin resistance and type II diabetes mellitus (T2DM). However, despite the 71 well-known association between obesity and T2DM, obesity may not trigger early metabolic 72 dysfunction as changes in glycaemic control are often reported before substantial gains in body 73 mass are observed. For example, recent human studies report that even brief periods (5-14 days) of 74 high-fat food intake can impair skeletal muscle insulin signalling (2) , and reduce both hepatic (3) and 75 whole-body insulin sensitivity (4, 5) . In each of these studies the experimental diets provided an 76 excess of energy as well as a high proportion of fat, and it is not yet clear if the observed 77 impairments in glycaemic control are a result of the additional energy, the high fat content of the 78 diets provided, or a combination of the two. Likewise, the effect of overfeeding with mixed 79 composition diets remains unknown. However, an overconsumption of carbohydrate-rich foods (5 80 days; +40% energy intake; 60% of energy from carbohydrate) has been reported to enhance skeletal 81 muscle insulin signalling, evidenced by increased tyrosine phosphorylation of insulin receptor-1 82 substrate (IRS-1) as well as increased IRS-1-associated phosphatidylinositol 3 (PI 3)-kinase 83 activity, whereas high-fat overfeeding (5 days; +40% energy intake; 50% of energy from fat) in the 84 same subjects was found to increase serine phosphorylation of IRS-1 and total expression of p85α 85 (2) . Hence it would seem that a lipid overload explains the reduction in insulin sensitivity, rather 86 than a positive energy balance alone. This also fits with the hypothesis that it is an accumulation of 87 reactive intra-myocellular lipid species, such as ceramide and diacylglycerol, that inhibits skeletal 88 muscle insulin signalling and impairs GLUT4 translocation (6, (7) (8) . 89
90
Of the previous literature, there has been considerable interest in identifying the molecular 91 mechanisms for peripheral (skeletal muscle) insulin resistance. However, whole-body glycaemic 92 control is coordinated by a variety of integrated physiological processes, involving multiple 93 hormones and their target tissues, and the effects of high-fat food intake on these hormonal 94 responses have received relatively little attention to date. Of particular interest are the two primary 95 incretin hormones: glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP). 96
These two hormones are secreted from the intestines in response to nutrient ingestion and it is 97 suggested that they act to control blood glucose levels by enhancing insulin secretion, suppressing 98 glucagon release and slowing gastric emptying (9) . Patients with T2DM are known to have a 99 diminished meal-induced secretion of GLP-1 (10, 11) . Not only this, but they can also become 100 resistant to the insulinotropic actions of GIP (12, (13) (14) . This loss of an incretin effect may be an 101 important contributor to postprandial hyperglycaemia in T2DM (15) . Evidence for this also comes 102 baseline anthropometric characteristics (height, weight and BMI). This information was then used 140 to estimate their resting energy expenditure (REE) according to the calculations described by 141
Mifflin et al., (27) . A standard correction for physical activity level (1.6 and 1.7 times REE for 142 females and males, respectively) was applied in order to estimate total daily energy requirements. 143
This information was then used to determine individual energy intakes for the week-long 144 overfeeding period (diet details described later). 145
146

Experimental design 147
After the initial pre-testing visit, subjects attended the laboratory for a mixed meal tolerance test 148 (MTT) (details of which can be seen in the experimental protocol below). Subjects were then 149 provided with all food to be consumed for the following 7 days. The experimental diet was 150 designed to be high in fat (65% total energy) and provide a severe energy excess (+50% kJ). All 151 foods were purchased and prepared by the research team. Mean energy and macronutrient intake 152 during the intervention period can be seen in Table 2 and a detailed example of typical daily food  153 intake can be seen in Table 3 . Foods such as processed meats, dairy products, and pastries were 154 used extensively throughout the diet intervention, and cooking instructions required subjects to fry 155 foods where possible and to avoid wasting any fat left over from the cooking process. Saturated, 156 monounsaturated and polyunsaturated fats made up 46 ± 0.9%, 37 ± 0.6%, and 9 ± 0.4% of the fat 157 intake, respectively. Upon completion of the 7-day overfeeding period, subjects returned to the 158 laboratory for a second MTT. 159 160 Diet records, physical activity and compliance during high-fat overfeeding 161
During the pre-testing visit, subjects were provided with standardised forms and digital kitchen 162 scales for the purpose of recording weighed food intake for 3-5 day prior to the first main trial. 163
Subjects also received detailed written and verbal instructions on how best to complete these 164 records. However, due to the well-known issues with self-reporting of energy intake (28) , especially 165 underreporting of food intake (29, (30) (31) , even amongst lean and very well-motivated subjects (32) , it 166 was decided that estimated energy requirements would provide a better overall baseline from which 167 to design and implement the overfeeding intervention. 168
169
Subjects were expected to eat all of the food provided, and the importance of this was made 170 explicitly clear to them during initial consultation and recruitment, but were told to report andSubjects were also given a copy of their diet plans and asked to tick off individual foods/meals as 175 they were consumed. Adherence to the diet was assessed by daily interviews that were conducted 176 when subjects collected their food bundles. Only one subject reported any issues with the diet, and 177 they returned part of an uneaten steak and ale pie from one of the meals. Other than this we are 178 confident that the diet was followed; as evidenced by a consistent weight gain in all subjects. 179
180
All subjects participated in physical activity on a regular basis and were required to continue this 181 throughout the overfeeding period. The written information and verbal instructions stated that 182 subjects should expect to gain a small amount of weight and that they should not attempt to offset 183 the additional energy intake by exercising longer, harder or more frequently. 184
185
Experimental protocol 186
On the experimental days (before and after overfeeding), subjects reported to the laboratory 187 between 07.00 and 09.00 h after an overnight fast of at least 10 h. After voiding and being weighed, containing potassium phosphate buffer (PBS), p-hydroxymercuribenzoic acid (PHMB) and sodium 207 hydroxide (NaOH) was mixed thoroughly with 2.5 mL of whole blood in 2.5 mL EDTA treated 208 tubes. Samples were then centrifuged at 1,750 g for 10 min after which 500 µL of the resulting 209 supernatant was removed and added to 50 µL of 1 M hydrochloric acid. Acidified samples were 210 centrifuged for a further 5 min at 1,750 g before being stored at -20°C until analysis. 211
212
Analytical procedures 213
Plasma samples were analysed using commercially available spectrophotometric assays for glucose, 214 triglyceride, HDL, LDL, total cholesterol (Horiba Medical, Northampton, UK) and NEFA (Randox, 215
County Antrim, UK) concentrations using a semi-automatic analyzer (Pentra 400; Horiba Medical, 216
Northampton, UK). The coefficient of variation (CV) for plasma glucose, triglyceride, HDL, LDL, 217 total cholesterol and NEFA was 0.5, 3.0, 1.6, 0.5, 0.3 and 4.1%, respectively. Serum insulin 218 concentrations were determined using an enzyme-linked immuno-sorbent assay (ELISA: EIA-2935, 219 DRG instruments GmBH, Germany) and the CV was 2%. Acylated ghrelin concentrations were 220 determined using an ELISA (EIA-A05106, SPI BIO, France) and the CV was 16%. Total plasma 221 GLP-1 and GIP concentrations were also determined via ELISA (EZGLP1T-36K and EZHGIP-222 54K, respectively; Merck Millipore, Darmstadt, Germany). The CV was 7% for GLP-1 and 5% for 223
GIP. 224 225
Area under the curve (AUC) 226
AUC for glucose and insulin was calculated using the trapezoidal rule with zero as the baseline. 227
228
Statistics 229
Data are presented as means ± standard error of the mean (SEM). Statistical analysis was performed 230 using SPSS (V21.0) for windows (SPSS Inc, Chicago, IL). Fasting metabolic responses to high-fat 231 overfeeding were compared using a paired t-test, whereas the dynamic hormonal and metabolic 232 responses to the MTT were compared using a two-way (pre vs. post-overfeeding) repeated 233 measures analysis of variance (ANOVA) and Bonferroni post hoc analysis where appropriate. 234
Statistical significance was accepted where p < 0.05. 235
All nine subjects gained body mass following 7 days of high-fat overfeeding (mean, 0.79 ± 0.14 kg; 239 range, 0.30-1.3 kg; p < 0.0001, Table 1 ), and their BMI increased by 0.27 ± 0.05 kg/m 2 (p = 0.002) 240 (Table 1) for reduced insulin sensitivity (hepatic and/or peripheral tissues) and elevated glucose 284 concentrations. Thus, an altered incretin effect does not appear to play a role in the early adaptive 285 response to overnutrition or the observed impairment in glycaemic control. Whilst we did observe 286 a small, but significant, increase in fasting GIP concentrations, the physiological relevance of this 287 remains unclear as fasting insulin concentrations were seemingly unaffected. 288
289
As mentioned previously, ghrelin concentrations are known to increase during fasting and decrease 290 following food intake (19) . This, combined with the observation that ghrelin administration 291 stimulates appetite and food intake (20, 21, 33) , has led to the suggestion that ghrelin is an appetite-292 regulating hormone that is responsible (at least partially) for eating behaviour. Thus, reduced 293 ghrelin levels reported in obese (23, (24) (25) and insulin resistant (34, 35) individuals might represent a 294 feedback loop by which the body attempts to reduce food intake within individuals that have been 295 exposed to a chronic positive energy balance. Ghrelin is also known to inhibit insulin secretion (36) , 296 and may, therefore, play a role in glucose homeostasis. Indeed, ghrelin knock-out mice exhibit 297 elevated basal insulin concentrations, enhanced glucose-stimulated insulin secretion, and improved 298 peripheral insulin sensitivity when compared to wild-type mice (37) . With this in mind, reduced 299 ghrelin levels might also be an attempt to lower glucose concentrations within hyperglycaemic 300 obese and insulin resistant populations. Given the discussion points above, we might have expected 301 to see a high-fat diet-induced decrease in fasting and/or postprandial acylated ghrelin 302 concentrations, especially as we observed significant gains in body mass (presumably body fat) and 303 increases in both fasting and postprandial glucose concentrations, but this was clearly not the case 304 ( Figure 1D ). However, our results are in accordance with other overfeeding studies ranging induration from 3-100 days (3, (38) (39) (40) . Thus it would seem that changes in circulating ghrelin 306 concentrations occur secondary to the development of obesity and/or insulin resistance rather than 307 in responses to relatively short-term positive energy balance or modest increases in blood glucose 308 concentrations. 309
310
Whilst the selected gut hormones demonstrated little response to the dietary intervention, high-fat 311 overfeeding resulted in a significant increase in fasting glucose and postprandial glucose and insulin 312 concentrations ( Figures 1A and 1B) , which is consistent with a number of previous human studies 313 (4, 5, (41) (42) (43) . Others have reported impairments in skeletal muscle insulin signalling without (possibly 314 before) a corresponding decrease in whole-body insulin sensitivity (2) , or reduced hepatic insulin 315 sensitivity without changes in peripheral glucose uptake (3) . The lack of mechanistic agreement 316 between some of these studies is most likely explained by differences in the duration of 317 overfeeding, the varying energy content and/or macronutrient composition of the diets 318 administered, or the particular method used for assessing insulin action and glycaemic control (oral 319
glucose tolerance test [OGTT] vs. hyperinsulinaemic euglycaemic clamp vs. mixed meal tolerance 320 test [MTT]). Where impairments in postprandial glycaemic control have been observed, it would 321
be useful to know the processes responsible for such an effect. Blood glucose concentrations are 322 governed by the balance between the rate of appearance of glucose from the gut, endogenous 323 glucose production (primarily from the liver), and peripheral glucose uptake (mainly skeletal 324 muscle). Therefore, the high-fat diet-induced increase in postprandial glucose concentration could 325 be due to a defect in one, or a number, of these processes, which obviously warrants further 326 investigation. 327
328
In addition to changes in glucose and insulin concentrations, we also observed a significant 329 decrease in fasting plasma triglyceride and NEFA concentrations after 7 days of high-fat 330 overfeeding. This is consistent with previous work by us (5) and others (2, 44, 45) and most likely 331 reflects a decrease in endogenous triglyceride production as a result of increased fat consumption 332 (46) and suppression of adipose tissue lipolysis as a result of consuming larger and/or more frequent 333 meals. It has been suggested that elevated NEFA concentrations might be responsible for the 334 development of insulin resistance and T2DM (47) . This notion has been fuelled by classical reports 335 of elevated NEFA concentrations in obesity (48) as well as acute studies in which NEFA have been 336 elevated by means of intravenous lipid-heparin infusion (49) . The later approach elevates NEFA by 337 activating lipoprotein lipase (LPL) located in the vascular endothelium and supplying a lipid-basedincreases, and lipid-heparin infusion trials often elicit NEFA concentration in excess of the disease 341 state that they aim to mimic (50) . Whilst our data tend to support this change in consensus, in that 342 we observed impaired glycaemic control at a time when fasting NEFA levels were reduced, we 343 should also point out that frequent consumption of high-fat foods throughout the week-long diet 344 intervention could have led to a considerable "spill-over" effect, whereby the hydrolysis of diet-345 derived circulating triglycerides could have driven regular postprandial increases in plasma NEFA. 346
347
It is also interesting to note that the high-fat-diet did not affect total or LDL cholesterol 348 concentrations as one might have expected, whereas HDL cholesterol actually increased following 349 the dietary intervention. In general, saturated fats (that were highly prevalent in the present study) 350 raise total and LDL cholesterol whereas polyunsaturated fats lower total and LDL cholesterol, and 351 both types of fat increase HDL cholesterol (51, 52) . It is likely that our study did not affect total or 352 LDL cholesterol levels due to the short duration of the diet intervention. Large scale population 353 studies have demonstrated a strong association between low levels of HDL and cardiovascular 354 disease risk (53, (54) (55) (56) ; a risk that is progressively reduced with increasing levels of HDL (57) . This has 355 been attributed to the potent anti-atherosclerotic properties of HDL (58) . However, it is important to 356 note that the high-fat diet-induced increase in HDL may not represent an improvement in the 357 plasma lipoprotein profile, as these diets have also been shown to reduce HDL particle uptake by 358 the liver through a downregulation in the B1 scavenger receptors, which may explain the apparent 359 rise in plasma concentrations (59) . 360 361 As a last point for consideration, our subjects were all healthy, young, lean and physically active, 362 and yet they still exhibited a rapid reduction in glycaemic control as a result of excessive 363 consumption of high-fat foods. Whilst there is a paucity of information regarding the metabolic 364 responses to overnutrition in humans, especially within at risk populations, one might expect even 365 greater deleterious responses in those who are already overweight, sedentary or elderly. 366 367
In conclusion, in this study we have provided further evidence that short-term, high-fat overfeeding 368 leads to impairments in glycaemic control, as indicated by a significant increase in meal-induced 369 glucose and insulin responses. Furthermore, the postprandial responses of GLP-1, GIP and acylated 370 ghrelin were not affected by the dietary intervention, suggesting that these selected gut hormones 371
are not responsive to brief periods of positive energy balance and/or severe lipid overload.
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Protein (g) 61
Carbohydrate (g) 47
Fat (g) 93
Energy (kJ) 5277
